[{"Assets_0_Q2_USD":417003000.0,"EarningsPerShareBasic_1_Q2_USD":-0.05,"EarningsPerShareBasic_2_Q2_USD":-0.14,"EarningsPerShareDiluted_1_Q2_USD":-0.05,"EarningsPerShareDiluted_2_Q2_USD":-0.14,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":2844000.0,"NetIncomeLoss_1_Q2_USD":-1558000.0,"NetIncomeLoss_2_Q2_USD":-4664000.0,"StockholdersEquity_0_Q2_USD":372978000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":33219487.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":32420105.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":33219487.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":32420105.0,"Ticker":"PEN","CIK":"1321732","name":"PENUMBRA INC","OfficialName":"Penumbra Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7821675869.0","Country":"nan","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20170808"}]